City State Bank’s Esperion Therapeutics ESPR Stock Holding History

City State Bank’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$632	Hold	200	–	–	﹤0.01%	770
2026 Q1	$548	Hold	200	–	–	﹤0.01%	749
2025 Q4	$740	Hold	200	–	–	﹤0.01%	723
2025 Q3	$530	Hold	200	–	–	﹤0.01%	710
2025 Q2	$197	Hold	200	–	–	﹤0.01%	731
2025 Q1	$288	Hold	200	–	–	﹤0.01%	722
2024 Q4	$440	Hold	200	–	–	﹤0.01%	691
2024 Q3	$330	Hold	200	–	–	﹤0.01%	709
2024 Q2	$444	Hold	200	–	–	﹤0.01%	692
2024 Q1	$1K	Hold	200	–	–	﹤0.01%	678
2023 Q4	$1K	Buy	+200	New	+$259	﹤0.01%	646
2023 Q1	–	Sell	-200	Closed	-$1K	–	687
2022 Q4	$1K	Hold	200	–	–	﹤0.01%	626
2022 Q3	$1K	Hold	200	–	–	﹤0.01%	633
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	636
2022 Q1	$1K	Hold	200	–	–	﹤0.01%	653
2021 Q4	$1K	Buy	+200	New	+$1.6K	﹤0.01%	643

Other funds holding ESPR

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

City State Bank's ESPR Position: Q2 2026 in Review

City State Bank held its Esperion Therapeutics (ESPR) position steady in Q2 2026 at 200 shares worth $632. The position accounts for ﹤0.01% of the portfolio, ranked #770.

City State Bank first reported a position in ESPR in Q4 2021 and has held it in 16 quarters since. The position peaked at $1K in Q1 2024. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

City State Bank held 200 shares of Esperion Therapeutics worth $632 as of Q2 2026.
City State Bank left its Esperion Therapeutics share count unchanged in Q2 2026.
Esperion Therapeutics made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #770 holding.
City State Bank first reported a position in Esperion Therapeutics in Q4 2021 and has held it in 16 quarters since.
City State Bank's Esperion Therapeutics position peaked at $1K in Q1 2024.
191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.